Instrument Inactif

Autres langues NVLS

Actions

Semi-conducteurs

Autres langues

18/04/16	Nivalis Therapeutics Appoints David Rodman, MD as Chief Medical Officer and Executive Vice President of Discovery
05/04/16	Nivalis Therapeutics Reaches 50 Percent Enrollment Milestone in Phase 2 Clinical Trial in Cystic Fibrosis
07/03/16	Nivalis Therapeutics Expands N91115 Clinical Development Program in Cystic Fibrosis
01/03/16	Nivalis Therapeutics Announces Appointment of Paul Sekhri to Its Board of Directors
29/02/16	Nivalis Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results
18/02/16	Nivalis Therapeutics Announces FDA Fast Track Designation for N91115 in Patients With Cystic Fibrosis
15/01/16	Nivalis Therapeutics Announces FDA Orphan Drug Designation for N91115 in Cystic Fibrosis
01/12/15	Nivalis Therapeutics Announces First Patient Dosed in Phase 2 Study of N91115 for Treatment of Cystic Fibrosis
10/11/15	Nivalis Therapeutics to Present at the Stifel Healthcare Conference 2015
02/11/15	Nivalis Therapeutics Reports Third Quarter and Nine-Month Financial Results for 2015
07/10/15	Nivalis Therapeutics Announces Positive Phase 1b Results for N91115 in Patients With Cystic Fibrosis and Plans to Initiate Phase 2 Trial
07/09/15	NOVELLUS SYS : Nivalis Therapeutics to Present at Two Upcoming Investor Conferences
14/08/15	NOVELLUS SYS : Nivalis Therapeutics Reports Financial Results for the Second Quarter 2015
03/08/15	Nivalis Therapeutics Reports Financial Results for the Second Quarter 2015
25/06/15	NOVELLUS SYS : Nivalis Therapeutics Announces Closing of Its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
25/06/15	NOVELLUS SYS : Nivalis Therapeutics Announces Pricing of Its Initial Public Offering
23/06/15	Nivalis Therapeutics Announces Closing of Its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
17/06/15	Nivalis Therapeutics Announces Pricing of Its Initial Public Offering
18/04/12	Novellus Systems, Inc. : NOVELLUS SYSTEMS REPORTS FIRST QUARTER RESULTS
06/03/12	Novellus Systems, Inc. : NOVELLUS SYSTEMS REPORTS MID-QUARTER UPDATE FOR FIRST QUARTER 2012
07/02/12	Novellus Systems, Inc. : NOVELLUS INTRODUCES VECTOR® STRATA™ FOR NEXT GENERATION, VERTICALLY INTEGRATED MEMORY (VIM) TECHNOLOGY
02/02/12	Novellus Systems, Inc. : NOVELLUS SYSTEMS REPORTS FOURTH QUARTER AND YEAR END RESULTS
23/01/12	Novellus Systems, Inc. : NOVELLUS ANNOUNCES AVAILABILITY AND TIMING OF FOURTH QUARTER AND YEAR-END 2011 FINANCIAL RESULTS WEBCAST
05/01/12	Novellus Systems, Inc. : NOVELLUS ANNOUNCES AVAILABILITY OF THE WEBCAST OF ITS PRESENTATION AT THE 14TH ANNUAL NEEDHAM GROWTH CONFERENCE
21/12/11	Novellus Systems, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Novellus Systems, Inc.

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Autres langues NVLS

Actions

Semi-conducteurs

Autres langues

Filtres